Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Riverstone Forms Advisory Committee.
- VANCOUVER, BRITISH COLUMBIA, Jun 19, 2007 CCNMatthews via COMTEX -- Riverstone Resources Inc. (the "Company") (TSX VENTURE:RVS) is pleased to report that an Advisory Committee is being formed to provide strategic direction to the manageme VANCOUVER, BRITISH COLUMBIA, Jun 19, 2007 CCNMatthews via COMTEX --...
- Research articles 2007-06-19
- Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
- Company Recommends Hemoglobin Target of 10-12 g/dL as Risk Management Approach
- Research articles 2007-09-11
- Pall Prion Removal Technology Presented to FDA Blood Products Advisory Committee
- EAST HILLS, N.Y. -- An update on Transmissible Spongiform Encephalopathies TSEs, including variant Creutzfeldt-Jakob Disease vCJD, the human form of "mad cow" disease, was a key topic at the Food & Drug Administration's Blood Products Advisory Committee meeting in Gaithersburg, Maryland today. Issues such as the number of people that...
- Research articles 2005-03-17
- FDA Advisory Committee Reviews Data on IDM Pharma's Junovan™ for Treatment of Osteosarcoma
- IRVINE, Calif. -- IDM Pharma, Inc. (NASDAQ: IDMI) today announced that the U.S. Food and Drug Administration's FDA Oncologic Drugs Advisory Committee ODAC voted 12 to 2 that the results of INT 0133, the Phase 3 trial, do not provide substantial evidence of effectiveness of Junovan mifamurtide in the treatment...
- Research articles 2007-05-09
Additional Resources
- DOBI Medical International, Inc. Inaugurates Business Advisory Committee; Barbara W. Hearst, John J. McAtee, Jr. And Others To Serve
- MAHWAH, NJ -- DOBI Medical International, Inc. (OTCBB-DBMI) announced today that it has created a Business Advisory Committee to assist the Company and Management as the Company continues to grow. The Business Advisory Committee will serve as a business corollary to the Company's existing Scientific and Medical Advisory Committee. Recently...
- Research articles 2004-07-07
- West Africa Gold Inc. Appoints New Chairman to Its Advisory Committee
- West Africa Gold Inc. (OTC BB: WAGI) announced today that it has appointed Dr. Wayne P. Colliston as the new Chairman of its Advisory Committee. This Committee will be initially focusing on the evaluation of all the geological data and Mining Reports in respect of the Company's initial five Mining...
- Research articles 2004-07-06
- FDA advisory panel gives Crestor thumbs up. (News).(the FDA advisory committee recommends the approval of AstraZeneca's Crestor)(Brief Article)
- THE FINISH LINE is in sight for AstraZeneca's Crestor rosuvastatin, which was recommended for approval by a Food and Drug Administration FDA advisory committee. A critical product for the company, Crestor has had a turbulent path to marketing a THE FINISH LINE is in...
- Research articles 2003-07-14
- Lilly Reels From Xigris Setback.(Food and Drug Administration advisory committee does not give approval)(Brief Article)
- Shares of Eli Lilly & Co. tumbled following the news that a Food & Drug Administration advisory committee failed to recommend approval for Xigris, the company's highly touted treatment for severe sepsis. The blow comes as Lilly reported a 7 Shares of Eli Lilly...
- Research articles 2001-10-22
- ART: Prominent biomedical specialist in lasers and optics Dr.Irving J. Bigio joins the Company's Scientific Advisory Committee.
- SAINT-LAURENT, Quebec, Dec 07, 2000 ART Advanced Research Technologies Inc. ART (TSE: "ARA") is pleased to announce the appointment of Dr. Irving J. Bigio to its Scientific Advisory Committee. The addition of Dr. Bigio to ART's Scientific Advisory Committee significantly strengthens the committee's...
- Research articles 2000-12-07
- Adherex Appoints Scientific and Clinical Advisory Committee; Leading International Experts to Advise Company on its Cancer Programs.
- DURHAM, NORTH CAROLINA and OTTAWA, ONTARIO, Apr 13, 2004 CCNMatthews via COMTEX -- Adherex Technologies Inc. (TSX: AHX), a biopharmaceutical company with a broad portfolio of products under development, today announced the appointment of the members of its Scientific and Clinical Advisory Committee. ...
- Research articles 2004-04-13
- People in Energy: Former Chairman of Clinton/Gore Climate Change Task Force Joins Pure Biofuels Advisory Committee
- ENERGY RESOURCE-21 February 2007-People in Energy: Former Chairman of Clinton/Gore Climate Change Task Force Joins Pure Biofuels Advisory CommitteeC2007 JeraOne - http://www.jeraone.com Pure Biofuels has appointed of two new members to its board of directors and has added two renewable energy experts to the company's Advisory Committee, including Roger...
- Research articles 2007-02-21
- People in Wireless News: Enforsys President Appointed to Advisory Committee
- Wireless News 07-27-2005 People in Wireless News: Enforsys President Appointed to Advisory Committee WIRELESS NEWS-July 28, 2005-People in Wireless News: Enforsys President Appointed to Advisory Committee C2005 10Meters - http:// www.10meters.com Enforsys Systems, a provider of...
- Research articles 2005-07-27
- FDA Advisory Committee to Review REZULIN Post-Marketing Data and Supplemental New Drug Application
- MORRIS PLAINS, N.J.--BUSINESS WIRE--Jan. 15, 1999--Following discussions with the U.S. Food and Drug Administration FDA, Warner-Lambert (NYSE:WLA) today announced that REZULIN troglitazone, the Company's oral therapy for type 2 diabetes, will be on the agenda at the regularly scheduled March 26th meeting of the Agency's Endocrinologic and Metabolic Drugs Advisory...
- Research articles 1999-01-15
- CEO Council Announces Meeting in Mundelein, Illinois, to Precede Chicago SEC Advisory Committee on Smaller Public Companies Hearing
- The CEO Council announced that it will hold its second meeting of public company executives and service providers in Chicago on August 8, 2005, preceding the SEC's Advisory Committee on Smaller Public Companies hearing, which will take place on August 9 and 10. The purpose of the meeting is to...
- Research articles 2005-07-27
- FDA Schedules Advisory Committee Review of BiDil
- LEXINGTON, Mass. -- NitroMed, Inc. (NASDAQ: NTMD) announced that the U.S. Food and Drug Administration stated on its website today that the Cardiovascular and Renal Drugs Advisory Committee plans to review the Company's New Drug Application NDA for the investigational drug BiDilR. BiDil is the Company's product candidate for the...
- Research articles 2005-04-29
- DepoCyt Scheduled for Dec. 18, 1997 FDA Advisory Committee Meeting
- SAN DIEGO, Calif.--BW HealthWire--Nov. 10, 1997--DepoTech Corp. (NASDAQ:DEPO) Monday announced that the U.S. Food and Drug Administration FDA has advised the company that it is currently scheduling its New Drug Application NDA for DepoCyt for review by the FDA's Oncologic Drug Advisory Committee Committee on Dec. 18, 1997.
- Research articles 1997-11-10
- FCC Appoints VeriSign to Commercial Mobile Service Alert Advisory Committee
- VeriSign, Inc. (NASDAQ: VRSN), the leading provider of intelligent infrastructure for the networked world, announced today that the Federal Communications Commission FCC has appointed the company to serve on its Commercial Mobile Service Alert Advisory Committee. Anthony M. Rutkowski, Vice President for Regulatory Affairs and Standards, will represent VeriSign on...
- Research articles 2006-12-12
- Grant Thornton LLP strongly supports report of SEC Advisory Committee on Improvements to Financial Reporting
- CHICAGO -- Grant Thornton LLP has endorsed the recommendations of the SEC Advisory Committee on Improvements to Financial Reporting CIFiR, calling the committee's report a catalyst for future action to make public company financial reporting more relevant, accessible and reliable. "Grant Thornton LLP enthusiastically supports the recommendations in the...
- Research articles 2008-08-01
- DepoCyt Scheduled for Nov. 16, 1998 FDA Advisory Committee Meeting
- SAN DIEGO and EMERYVILLE, Calif.--BW HealthWire--Oct. 16, 1998--DepoTech Corp. (Nasdaq:DEPO) today announced that the U.S. Food and Drug Administration FDA has advised the company that it is currently scheduling its New Drug Application NDA for DepoCytTM for the treatment of neoplastic meningitis NM from lymphomas for review by the FDA's...
- Research articles 1998-10-17
- North American Vaccine Announces Update On FDA Advisory Committee Meeting
- BELTSVILLE, Md.--BUSINESS WIRE--Nov. 26, 1996--North American Vaccine (AMEX:NVX) maintains its policy of not commenting on interactions with the U.S. Food and Drug Administration ("FDA") in, or the status of, the FDA's review of the company's products or on rumors or press reports appearing in the media regarding the business operations...
- Research articles 1996-11-26
- << Previous
- page 1 of 1
- Next >>